Alison Brannan

Director Of Scientific Operations at Cignpost Diagnostics

Alison Brannan is an accomplished professional with extensive experience in sales and operations management across various industries. Currently serving as the Director of Scientific Operations at Cignpost Diagnostics since July 2020, Alison has also held the roles of Client Account Manager for Scotland and Director Of Airport Client Operations at Express Test. Prior to this, Alison sought new opportunities from August 2019 to July 2020 as a Regional Sales Manager, and worked as a Regional Sales Manager at Lyreco UK and Ireland from August 2015 to January 2019. Earlier career highlights include a tenure as National Sales Director at British Gas and leadership roles at BSkyB, where Alison progressed from Area Sales Manager to Head of SRS. Alison's educational background is rooted in Wishaw, Lanarkshire, Scotland.

Location

Glasgow, United Kingdom

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Cignpost Diagnostics

Cignpost Diagnostics, LTD. is a leading health and diagnostics company, operating globally to empower and guide people towards living a healthier life. By combining scientific expertise with a relentless focus on people, Cignpost has quickly evolved to become a global leader in COVID-19 screening and health diagnostics, establishing safe, managed environments across a range of sectors, including elite sports, defence, film and TV production, and financial services. Following success with clients including Netflix, the BBC and the PGA European Tour, today services extend beyond testing, providing strategic consultancy on business continuity and customised end-to-end solutions to meet client needs. Through a network of regional health care centres, Cignpost ExpressTest is the UK’s leading and largest COVID test provider for consumers, particularly in the travel sector, with testing centres across the country including at Heathrow, Gatwick, Edinburgh, Birmingham Airport, Reading and Brent Cross.